temocillin has been researched along with Intraabdominal Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carryn, S; Dugernier, T; Laterre, PF; Mouton, JW; Muller, AE; Tulkens, PM; Van de Velde, S; Wittebole, X | 1 |
Alexandre, K; Cattoir, V; Chau, F; Fantin, B; Guérin, F; Lefort, A; Massias, L | 1 |
1 trial(s) available for temocillin and Intraabdominal Infections
Article | Year |
---|---|
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Enterobacteriaceae Infections; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Organization and Administration; Penicillins; Prospective Studies; Respiratory Tract Infections | 2015 |
1 other study(ies) available for temocillin and Intraabdominal Infections
Article | Year |
---|---|
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Injections, Subcutaneous; Intraabdominal Infections; Mice; Microbial Sensitivity Tests; Penicillins; Plasma; Spleen; Survival Analysis; Treatment Outcome | 2016 |